Page last updated: 2024-09-05

nk3201 and Cardiac Remodeling, Ventricular

nk3201 has been researched along with Cardiac Remodeling, Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, T; Jin, D; Kitada, K; Kitaura, Y; Matsumoto, C; Matsumura, Y; Miyamura, M; Miyazaki, M; Mori, T; Ohkita, M; Okada, Y; Takai, S; Ukimura, A; Yamashita, C1
Kamoshita, K; Miyazaki, M; Sukenaga, Y; Takai, S1

Reviews

1 review(s) available for nk3201 and Cardiac Remodeling, Ventricular

ArticleYear
Development of the chymase inhibitor as an anti-tissue-remodeling drug: myocardial infarction and some other possibilities.
    Japanese journal of pharmacology, 2002, Volume: 90, Issue:3

    Topics: Acetamides; Animals; Chymases; Cricetinae; Myocardial Infarction; Pyrimidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Ventricular Remodeling

2002

Other Studies

1 other study(ies) available for nk3201 and Cardiac Remodeling, Ventricular

ArticleYear
Chymase plays an important role in left ventricular remodeling induced by intermittent hypoxia in mice.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:1

    Topics: Acetamides; Aldehydes; Angiotensin II; Animals; Body Weight; Chymases; Gene Expression; Hemodynamics; Hypoxia; Immunohistochemistry; Interleukin-6; Lipid Peroxides; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; NADP; Organ Size; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ventricular Remodeling

2009